A comparative analysis of BCP-ALL patients using the public dataset GSE10792 demonstrated significantly higher expression levels of ERG in ETV6::RUNX1-positive than in BCR::ABL1-positive patients, while ETS2 showed no significant difference (Figure 5D), supporting our findings in cell lines. Here, ETS2 is linked to acute lymphoblastic leukemia.